Search
centrally-acting ACE inhibitor
Indications:
- may slow cognitive decline in patients with dementia
- effect is small & of unknown clinical significance
- hypertension
- diabetic nephropathy
- nondiabetic proteinuric nephropathy
- chronic heart failure
- left ventricular systolic dysfunction
- myocardial infarction
- left ventricular diastolic dysfunction
- scleroderma, scleroderma renal crisis
- migraine prophylaxis
- ischemic stroke
- cystinuria, cysteine renal calculi
Interactions
drug adverse effects of renin-angiotensin-aldosterone system inhibitors (RAAS inhibitors)
monitor with ACE inhibitors
Specific
captopril (Capoten)
fosinopril (Monopril)
lisinopril (Prinivil, Zestril)
perindopril (Aceon, Coversyl)
ramipril (Altace)
trandolapril (Mavik, indolapril)
General
angiotensin-converting enzyme (ACE) inhibitor
References
- Gao Y, O'Caoimh R, Healy L et al
Effects of centrally acting ACE inhibitors on the rate of
cognitive decline in dementia.
BMJ Open 2013;3:e002881
PMID: 23887090
http://bmjopen.bmj.com/content/3/7/e002881
- Deprecated Reference